Search

Your search keyword '"Faedi, Marina"' showing total 15 results

Search Constraints

Start Over You searched for: Author "Faedi, Marina" Remove constraint Author: "Faedi, Marina" Publisher american society of clinical oncology (asco) Remove constraint Publisher: american society of clinical oncology (asco)
15 results on '"Faedi, Marina"'

Search Results

1. Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma (GBM) patients (PTS).

2. REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib (REG) activity in relapsed glioblastoma (GBM) patients (PTS).

3. A phase II trial of temozolomide (TMZ) 1 week on/1 week off as initial treatment for high risk low grade oligodendroglial tumors: An AINO (Italian Association for Neuro-Oncology) study.

4. Bone health management in early breast cancer patients: An Italian osteoncology center experience.

5. Does the duration of adjuvant temozolomide impact survival in glioblastoma patients? A retrospective analysis from an Italian registry (GLIOSTRY).

6. Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

8. GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.

9. Association of high volume center with survival for glioblastoma patients: Results from a prospective population-based registry (PERNO).

11. Final results from a large prospective Italian population study on glioblastoma and correlations with MGMT status: The Project of Emilia-Romagna Region in Neuro-oncology (PERNO).

12. Analysis of long-term survival in patients with glioblastoma.

13. Trastuzumab-induced cardiotoxicity in early breast cancer: Evaluation of possible risk and protective factors.

14. Natural history of glioblastoma in the modern era: Longitudinal results from a large prospective Italian register.

15. Phase II trial of dose-dense temozolomide as initial treatment for progressive low-grade oligodendroglial tumors: A multicentric study of the Italian Association of Neuro-Oncology (AINO).

Catalog

Books, media, physical & digital resources